Figure 8.
(a) Plasma adiponectin; (b) serum glucose; (c) Urinary aldosterone levels; (d) % Change in Plasma volume; and (e) Systolic blood pressure in normal male SD rats chronically treated with vehicle (VEH) or rosiglitazone at the dose of 80 mg/kg·body weight (RGZ), (n = 10/treatment group). Data were represented as means ± SEM. Means were compared using unpaired t-test. *indicates a significant difference between the groups (p < 0.05).